Ann K Sullivan
Biographic Data
| ID | 7446630 |
|---|---|
| NAME | Ann K Sullivan |
| GIVEN NAMES | Ann K |
| FAMILY NAME | Sullivan |
| SIGNATURE | SULLIVAN A K |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2016 |
| LATEST PUBLICATION YEAR | 2019 |
| H-INDEX | 0 |
Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants
These analyses suggest PrEP remains a feasible and effective HIV prevention method for GBM engaging in chemsex, a practise which is prevalent in this group and has been associated with increased HIV transmission risk
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD)
BACKGROUND: Randomised placebo-controlled trials have shown that daily oral pre-exposure prophylaxis (PrEP) with tenofovir-emtricitabine reduces the risk of HIV infection. However, this benefit could be counteracted by risk compensation in users of PrEP. We did the PROUD study to assess this effect. METHODS: PROUD is an open-label randomised trial done at 13 sexual health clinics in England. We enrolled HIV-negative gay and other men who have sex…
No prominent works on this page.
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD)
BACKGROUND: Randomised placebo-controlled trials have shown that daily oral pre-exposure prophylaxis (PrEP) with tenofovir-emtricitabine reduces the risk of HIV infection. However, this benefit could be counteracted by risk compensation in users of PrEP. We did the PROUD study to assess this effect. METHODS: PROUD is an open-label randomised trial done at 13 sexual health clinics in England. We enrolled HIV-negative gay and other men who have sex…
Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants
These analyses suggest PrEP remains a feasible and effective HIV prevention method for GBM engaging in chemsex, a practise which is prevalent in this group and has been associated with increased HIV transmission risk
Antiretroviral therapy (2 works) · Emtricitabine (2 works) · Family medicine (2 works) · HIV Research and Treatment (2 works) · HIV/AIDS Research and Interventions (2 works) · Medicine (2 works) · Men who have sex with men (2 works) · Pre-exposure prophylaxis (2 works) · Viral load (2 works) · Alternative medicine (1 work)